<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=799546403794687&amp;ev=PageView&amp;noscript=1">
Blogs

Colorado Clinical and Translational Sciences Institute (CCTSI) News and Stories

Genetics

Research    Genetics    CCTSI    rare disease

Researchers Shed Light on a Rare Genetic Disease in Children

You probably learned about cilia in high school biology class. The tiny hairlike structures line our nasal passages, ears and airways. Children born with primary ciliary dyskinesia (PCD), a rare inherited disease, have problems with the cilia that prevent them from moving mucus and inhaled particles and germs out of their airways, causing mucus to build up, leading to ear, sinus and lung infections.


Author Wendy Meyer | Publish Date December 07, 2022
Full Story

Colorado Clinical and Translational Sciences Institute (CCTSI) News Topics

Colorado Clinical and Translational Sciences Institute (CCTSI) In the News

Daily Camera

CU Boulder center supports human biomedical research

news outletDaily Camera
Publish DateNovember 23, 2023

Chris DeSouza, who leads the Clinical Translational Research Center at CU Boulder, said the center is the only one housed in an undergraduate non-medical campus nationwide. It’s supporting more than a dozen active research protocols at CU Boulder.

Full Story
Colorado Public Radio

Do you have long COVID? This Colorado research is trying to help identify just what it does and what to do about it

news outletColorado Public Radio
Publish DateSeptember 21, 2023

The outpatient clinics of the Colorado Clinical and Translational Sciences Institute (CCTSI) on the CU Anschutz campus was one of the sites where researchers worked.

Full Story
UCHealth

Researchers are testing treatments for long COVID symptoms, ranging from brain fog to shortness of breath

news outletUCHealth
Publish DateSeptember 12, 2023

The studies, which are part of the RECOVER initiative, target a host of symptoms that are most troubling for patients enduring long-term health effects after COVID-19.

Full Story